Plunkett Research Online: Vansen Pharma Inc

VANSEN PHARMA INC (VNSN:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vansen Pharma Inc is a specialty pharmaceutical company expanding its commercial presence by adding products through in-licensing, co-promotion and acquisitions......



Vansen Pharma Inc
Ticker: VNSN
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 702 843-0456
Fax: 702-843-0459
Address: 6955 N Durango Drive
Suite 1115-754
Las Vegas, NV 89149 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Patrick FrankhamDirector
Ahmad Doroudian, Ph.D.Director/President/CEO
See More
Vansen Pharma Inc is a specialty pharmaceutical company expanding its commercial presence by adding products through in-licensing, co-promotion and acquisitions......See More See More

Auditor: Saturna Group Chartered Accountants LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2012201120102009
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: